BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 9398852)

  • 21. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A female infant with Frasier syndrome showing splice site mutation in Wilms' tumor gene (WT1) intron 9.
    Fujita S; Sugimoto K; Miyazawa T; Yanagida H; Tabata N; Okada M; Takemura T
    Clin Nephrol; 2010 Jun; 73(6):487-91. PubMed ID: 20497763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C; Romaniuk PJ
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frasier syndrome: a rare syndrome with WT1 gene mutation in pediatric urology].
    Zugor V; Zenker M; Schrott KM; Schott GE
    Aktuelle Urol; 2006 Jan; 37(1):64-6. PubMed ID: 16440249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome.
    Subbiah V; Huff V; Wolff JE; Ketonen L; Lang FF; Stewart J; Langford L; Herzog CE
    Pediatr Blood Cancer; 2009 Dec; 53(7):1349-51. PubMed ID: 19653292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the clinical spectrum of Frasier syndrome.
    Gwin K; Cajaiba MM; Caminoa-Lizarralde A; Picazo ML; Nistal M; Reyes-Múgica M
    Pediatr Dev Pathol; 2008; 11(2):122-7. PubMed ID: 17378674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
    Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
    Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Causes of ambiguous external genitalia in neonates].
    Zdravković D; Milenković T; Sedlecki K; Guć-Sćekić M; Rajić V; Banićević M
    Srp Arh Celok Lek; 2001; 129(3-4):57-60. PubMed ID: 11534268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Japanese case with Frasier syndrome caused by the splice junction mutation of WT1 gene.
    Okuhara K; Tajima S; Nakae J; Sasaki S; Tochimaru H; Abe S; Fujieda K
    Endocr J; 1999 Oct; 46(5):639-42. PubMed ID: 10670748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 46,XY female DSD patient with bilateral gonadoblastoma, a novel SRY missense mutation combined with a WT1 KTS splice-site mutation.
    Hersmus R; van der Zwan YG; Stoop H; Bernard P; Sreenivasan R; Oosterhuis JW; Brüggenwirth HT; de Boer S; White S; Wolffenbuttel KP; Alders M; McElreavy K; Drop SL; Harley VR; Looijenga LH
    PLoS One; 2012; 7(7):e40858. PubMed ID: 22815844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonad development in Drash and Frasier syndromes depends on WT1 mutations.
    Jaubert F; Vasiliu V; Patey-Mariaud de Serre N; Auber F; Jeanpierre C; Gubler MC; Nihoul-Fékété C; Fellous M
    Arkh Patol; 2003; 65(2):40-4. PubMed ID: 15357247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diaphragmatic hernia in Denys-Drash syndrome.
    Devriendt K; Deloof E; Moerman P; Legius E; Vanhole C; de Zegher F; Proesmans W; Devlieger H
    Am J Med Genet; 1995 May; 57(1):97-101. PubMed ID: 7645607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].
    Wasilewska A; Zoch-Zwierz W; Tenderenda E; Rybi-Szumińska A; Kołodziejczyk Z
    Pol Merkur Lekarski; 2009 Jun; 26(156):642-4. PubMed ID: 19711733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.